Levetiracetam
Product manufactured by Remedyrepack Inc.
Indications and Purposes
| 1 Indications & Usage Levetiracetam Tablet Is Indicated For Adjunctive Therapy In The Treatment Of: • Partial Onset Seizures In Patients One Month Of Age And Older With Epilepsy (1.1) • Myoclonic Seizures In Patients 12 Years Of Age And Older With Juvenile Myoclonic Epilepsy (1.2) • Primary Generalized Tonic-Clonic Seizures In Patients 6 Years Of Age And Older With Idiopathic Generalized Epilepsy (1.3) 1.1 Partial Onset Seizures Levetiracetam Tablet Is Indicated As Adjunctive Therapy In The Treatment Of Partial Onset Seizures In Adults And Children 1 Month Of Age And Older With Epilepsy. 1.2 Myoclonic Seizures In Patients With Juvenile Myoclonic Epilepsy Levetiracetam Tablet Is Indicated As Adjunctive Therapy In The Treatment Of Myoclonic Seizures In Adults And Adolescents 12 Years Of Age And Older With Juvenile Myoclonic Epilepsy. 1.3 Primary Generalized Tonic-Clonic Seizures Levetiracetam Tablet Is Indicated As Adjunctive Therapy In The Treatment Of Primary Generalized Tonic-Clonic Seizures In Adults And Children 6 Years Of Age And Older With Idiopathic Generalized Epilepsy. |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Levetiracetam |
|
ZINC1547851 |